September 6, 2017 06:59 AM EDTUpdated May 26, 08:50 PM

Voyager Therapeutics adds proof its gene therapy for Parkinson's can work, shares soar

John Carroll

Editor & Founder

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER

ENDPOINTS CAREERS

COO / Head of Operations (Stealth Portfolio Company)‬ ‭

Autonomy Bio Inc.

San Francisco, CA 94107, USA

view job offer post your job now

TRENDING NOW

Lilly shuffles key executive positions; Mikael Dolsten takes another post-Pfizer assignment

Revolution’s KRAS drugs appear competitive in several lung cancer settings

Iovance stock plummets after lowered full-year guidance, missed analyst expectations for Amtagvi

Chronic care startup Omada Health files to go public

Corvus' early-phase atopic dermatitis data prompt stock rally

sponsored

In one of the riskiest industries — Biotech — a surefire way to neutralize some of that risk emerges